FASLG and antiphospholipid syndrome: These include heterogeneity in study designs, inclusion of women with low positive aPL levels in those women considered positive, different definitions of late pregnancy loss amongst studies, and population heterogeneity with respect to the clinical phenotype of antiphospholipid syndrome.